Sapiens Reports Second Quarter 2019 Financial Results

HOLON, Israel, Aug. 5, 2019 /PRNewswire/ -- Sapiens International Corporation, SPNS SPNS, a leading global provider of software solutions for the insurance industry, and a member of the Formula Group FORTY FORT, today announced its financial results for the second quarter ended June 30, 2019.

Sapiens Logo

 

Summary Results for Second Quarter 2019 (USD in millions, except per share data)





GAAP

% Change

Non-GAAP

% Change



June 30, 2019

June 30, 2018



June 30, 2019

June 30, 2018



Revenue

$79.5

$72.2

10.2%

$79.5

$72.5

9.6%

Gross Profit

$31.5

$26.9

17.1%

$34.8

$30.4

14.3%

Gross Margin

39.6%

37.2%

240 bps

43.8%

42.0%

180 bps

Operating Income

$9.5

$4.9

91.8%

$12.6

$9.6

31.4%

Operating Margin

11.9%

6.8%

510 bps

15.8%

13.2%

260 bps

Net income (*)

$6.8

$2.0

239.6%

$9.5

$6.4

49.5%

Diluted EPS

$0.14

$0.04

236%

$0.19

$0.13

45.4%

















 

(*) Attributable to Sapiens' shareholders

"Sapiens priorities for 2019 are growth and margin expansion. In the second quarter we delivered on both of these goals. Top line non-GAAP revenue increased 9.6% and non-GAAP operating margin improved 260 basis points. Growth and profitability in the quarter tie directly to executing on our key objectives to win new customers, cross sell to existing customers, leverage our offshore capabilities, and scale revenue over our efficient cost structure. Our improving margins support our build-out of sales and customer support teams and our investment in our offshore capabilities, particularly in India. As we head into the second half of the year, our sustained performance gives us confidence that our strategy is working, and we are dedicated to further improving shareholder value through long-term, sustainable growth." said Roni Al-Dor, president and CEO, Sapiens.

"Looking out to the remainder of 2019, I'm encouraged by our pipeline of business and anticipate annual growth of over 10%. We are forecasting non-GAAP revenue in a range of $318 - $323 million, however we now expect revenues to be on the higher end of this range" concluded Roni Al-Dor. "The increase in revenue and the leverage from improved economies of scale allows us to increase the guidance for non-GAAP operating margin in a range of 15.6% - 15.8%, compared to our previous guidance of 15.2% - 15.6%" 

Quarterly Results Conference Call

Management will host a conference call and webcast on August 5, 2019 at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results.

Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

North America (toll-free): + 1-888-668-9141; International: +972-3- 9180610; UK: 0-800-917-5108

The live webcast of the call can be viewed on Sapiens' website at: https://www.sapiens.com/investor-relations/ir-events-presentations/

If you are unable to join live, a replay of the call will be accessible until August 13, 2019, as follows:

North America: 1-877-456-0009; International: +972-3-925-5921

A recorded version of the webcast will also be available via the Sapiens website, for three months at the same location.

Non-GAAP Financial Measures

This press release contains the following non-GAAP financial measures: non-GAAP revenue, non-GAAP gross profit, non-GAAP operating income, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation,  restructuring and cost reduction costs, tax adjustments related to non-GAAP adjustments, and acquisition-related costs, which pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

The Company defines Adjusted EBITDA as net profit, adjusted for valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalized of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies to help investors understand the operational performance of their business.

The Company uses Adjusted EBITDA as a measurement of its operating performance, and reconciles Non-GAAP Operating Income to Adjusted EBITDA, adjusted for amortization and capitalization of capitalized software and amortization other intangible assets, stock-based compensation and acquisition-related costs, and valuation adjustment on acquired deferred revenues. The Company uses Adjusted EBITDA, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business.

The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow while reducing the amounts for capitalization of software development costs and capital expenditures, and adds back  cash payments made for  former acquisitions in respect of  future performance targets and retention criteria as determined upon acquisition date of the respective acquired company,   and were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

About Sapiens

Sapiens International Corporation empowers insurers to succeed in an evolving industry. The company offers digital software platforms, solutions and services for the property and casualty, life, pension and annuity, reinsurance, financial and compliance, workers' compensation and financial markets. With more than 35 years of experience delivering to over 450 organizations globally, Sapiens has a proven ability to satisfy customers' core, data and digital requirements. For more information: www.sapiens.com   

Forward Looking Statement

Some of the statements in this press release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities and Exchange Act of 1934 and the United States Private Securities Litigation Reform Act of 1995. Words such as "will," "expects," "believes" and similar expressions are used to identify these forward-looking statements (although not all forward-looking statements include such words). These forward-looking statements, which may include, without limitation, projections regarding our future performance and financial condition, are made on the basis of management's current views and assumptions with respect to future events. Any forward-looking statement is not a guarantee of future performance and actual results could differ materially from those contained in the forward-looking statement.

These statements speak only as of the date they were made, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. We operate in a changing environment. New risks emerge from time to time and it is not possible for us to predict all risks that may affect us. For more information regarding these risks and uncertainties, as well as certain additional risks that we face, please refer to the Risk Factors detailed in Item 3 of Part III of our Annual Report on Form 20-F for the year ended December 31, 2018, and subsequent reports and registration statements filed from time to time with the Securities and Exchange Commission.

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES   

CONDENSED CONSOLIDATED STATEMENTS OF INCOME   

U.S. dollars in thousands (except per share amounts)









  Three months ended



  Six months ended





 June 30



 June 30





2019



2018



2019



2018







 (unaudited)



 (unaudited)



 (unaudited)



 (unaudited)





















 Revenue



79,529



72,164



156,316



143,159

 Cost of revenue



48,075



45,305



95,055



89,272





















 Gross profit



31,454



26,859



61,261



53,887





















 Operating expenses:



















 Research and development, net



8,923



8,633



17,700



17,780



 Selling, marketing, general and administrative



13,077



13,298



26,030



26,482

 Total operating expenses



22,000



21,931



43,730



44,262





















 Operating income



9,454



4,928



17,531



9,625





















 Financial expense, net



434



1,316



1,488



2,154

 Taxes and other expenses, net



2,154



1,483



4,001



2,514









































 Net income



6,866



2,129



12,042



4,957





















 Attributable to non-controlling interest



26



115



47



107





















 Net income attributable to Sapiens' shareholders



6,840



2,014



11,995



4,850









































 Basic earnings per share



0.14



0.04



0.24



0.10





















 Diluted earnings per share



0.14



0.04



0.24



0.10







































Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)



50,002



49,785



49,994



49,779



















Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)



50,530



49,998



50,430



50,033

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED NON-GAAP STATEMENTS OF INCOME   

U.S. dollars in thousands (except per share amounts)  









  Three months ended



  Six months ended







 June 30



 June 30







2019



2018



2019



2018







 (unaudited)



 (unaudited)



 (unaudited)



 (unaudited)





















 Revenue



79,529



72,542



156,316



143,627

 Cost of revenue



44,735



42,105



88,418



82,906





















 Gross profit



34,794



30,437



67,898



60,721





















 Operating expenses:



















 Research and development, net



10,493



9,926



20,662



20,250



 Selling, marketing, general and administrative



11,720



10,936



22,905



22,033

 Total operating expenses



22,213



20,862



43,567



42,283





















 Operating income



12,581



9,575



24,331



18,438





















 Financial expense, net



434



1,316



1,488



2,154

 Taxes and other expenses



2,580



1,762



4,865



3,488









































 Net income



9,567



6,497



17,978



12,796





















 Attributable to non-controlling interest



26



115



47



107





















 Net income attributable to Sapiens' shareholders



9,541



6,382



17,931



12,689









































 Basic earnings per share



0.19



0.13



0.36



0.25





















 Diluted earnings per share



0.19



0.13



0.36



0.25







































Weighted average number of shares outstanding used to compute basic earnings per share (in thousands)



50,002



49,785



49,994



49,779



















Weighted average number of shares outstanding used to compute diluted earnings per share (in thousands)



50,530



49,998



50,430



50,033



 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP RESULTS

U.S. dollars in thousands (except per share amounts)









Three months ended



Six months ended





June 30,



June 30,





2019



2018



2019



2018





(unaudited)



(unaudited)



(unaudited)



(unaudited)



















GAAP revenue



79,529



72,164



156,316



143,159

Valuation adjustment on acquired deferred revenue



-



378



-



468

Non-GAAP revenue



79,529



72,542



156,316



143,627





































GAAP gross profit



31,454



26,859



61,261



53,887

Valuation adjustment on acquired deferred revenue



-



378



-



468

Amortization of capitalized software



1,390



1,152



2,731



2,407

Amortization of other intangible assets



1,950



2,048



3,906



3,959

Non-GAAP gross profit



34,794



30,437



67,898



60,721



















GAAP operating income



9,454



4,928



17,531



9,625

Gross profit adjustments



3,340



3,578



6,637



6,834

Capitalization of software development



(1,570)



(1,293)



(2,962)



(2,470)

Amortization of other intangible assets



540



706



1,075



1,628

Stock-based compensation



288



499



741



1,086

Acquisition-related costs *)



529



1,157



1,309



1,735

Non-GAAP operating income



12,581



9,575



24,331



18,438



















  GAAP net income attributable to Sapiens' shareholders



6,840



2,014



11,995



4,850

  Operating income adjustments



3,127



4,647



6,800



8,813

  Tax and other



(426)



(279)



(864)



(974)

  Non-GAAP net income attributable to Sapiens' shareholders



9,541



6,382



17,931



12,689





















(*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

 

 

Summary of NON-GAAP Financial Information 

U.S. dollars in thousands (except per share amounts) 























Q2 2019



Q1 2019



Q4 2018



Q3 2018



Q2 2018





















Revenues

79,529



76,787



73,433



73,237



72,542

Gross profit

34,794



33,104



31,320



30,903



30,437

Operating income

12,581



11,750



10,849



10,273



9,575

Net income to Sapiens' shareholders

9,541



8,390



7,826



7,548



6,382

Adjusted EBITDA

13,358



12,524



11,797



11,236



10,385





















Basic earnings per share

0.19



0.17



0.16



0.15



0.13

Diluted earnings per share

0.19



0.17



0.16



0.15



0.13

 

 

Non-GAAP Revenues by Geographic Breakdown 

U.S. dollars in thousands























Q2 2019



Q1 2019



Q4 2018



Q3 2018



Q2 2018





















North America

39,216



38,149



34,974



36,734



34,606

Europe

33,881



32,193



30,850



30,611



32,518

Asia Pacific

3,515



3,670



3,140



3,480



3,305

South Africa

2,917



2,775



4,469



2,412



2,113





















Total

79,529



76,787



73,433



73,237



72,542

 

 

Adjusted Free Cash-Flow

U.S. dollars in thousands





Q2 2019



Q1 2019



Q4 2018



Q3 2018



Q2 2018





















Cash-flow from operating activities

15,507



10,550



11,509



6,370



658

Increase in capitalized software

      development costs

(1,570)



(1,392)



(1,382)



(1,308)



(1,293)

Capital expenditures

(1,079)



(641)



(204)



(831)



(402)

Free cash-flow

12,858



8,517



9,923



4,231



(1,037)





















Cash payments attributed to acquisition-related costs(*) (**)

1,692



1,608



790



-



256





















Adjusted free cash-flow

14,550



10,125



10,713



4,231



(781)

(*) Included in cash-flow from operating activities

(**) Acquisition-related payments pertain to payments on behalf of M&A agreements related to future performance targets and retention criteria, as well as third-party services, such as, tax, accounting and legal rendered until the acquisition date.

 

 

Adjusted EBITDA Calculation 

U.S. dollars in thousands  







Three months ended



Six months ended





 June 30



 June 30





2019



2018



2019



2018



















GAAP operating profit



9,454



4,928



17,531



9,625



















Non-GAAP adjustments:

















Amortization of capitalized software



1,390



1,152



2,731



2,407

Amortization of other intangible assets



2,490



2,754



4,981



5,587

Capitalization of software development



(1,570)



(1,293)



(2,962)



(2,470)

Stock-based compensation



288



499



741



1,086

Acquisition-related costs



529



1,157



1,310



1,735

Valuation adjustment on acquired deferred revenue



-



378



-



468



















Non-GAAP operating profit



12,581



9,575



24,332



18,438



















Depreciation



777



810



1,550



1,892



















Adjusted EBITDA



13,358



10,385



25,882



20,330



 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands









June 30,



December 31,







2019



2018







 (unaudited)



 (unaudited)













 ASSETS























 CURRENT ASSETS











Cash and cash equivalents



77,282



64,628



Trade receivables, net and unbilled receivables



58,827



59,159



Other receivables and prepaid expenses



7,615



6,224















Total current assets



143,724



130,011













 LONG-TERM ASSETS











Property and equipment, net



9,264



8,515



Severance pay fund



4,941



4,699



Goodwill and intangible assets, net



230,069



231,348



Operating lease right-of-use assets



54,106



-



Other long-term assets



4,885



4,292















Total long-term assets



303,265



248,854













 TOTAL ASSETS



446,989



378,865













LIABILITIES AND EQUITY





















 CURRENT LIABILITIES











Trade payables



6,491



6,149



Current maturities of Series B Debentures



9,898



9,898



Accrued expenses and other liabilities



49,390



46,999



Current maturities of operating lease liabilities



8,107



-



Deferred revenue



22,782



18,057















Total current liabilities



96,668



81,103













 LONG-TERM LIABILITIES











Series B Debentures, net of current maturities



58,763



68,577



Deferred tax liabilities



9,692



11,681



Other long-term liabilities



7,723



9,398



Long-term operating lease liabilities



48,105



-



Accrued severance pay



5,946



5,622















Total long-term liabilities



130,229



95,278

























EQUITY





220,092



202,484













TOTAL LIABILITIES AND EQUITY



446,989



378,865

 

 

SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

CONSOLIDATED STATEMENT OF CASH FLOW

U.S. dollars in thousands 





For the six months ended June 30,



2019

2018



(unaudited)

(unaudited)

 

Cash flows from operating activities:





Net income

12,042

4,957

Reconciliation of net income (loss) to net cash provided by operating

activities:





Depreciation and amortization

9,262

9,886

Accretion of discount on Series B Debentures

84

94

Capital gain from sale of property and equipment

(129)

-

Stock-based compensation related to options issued to employees

741

1,086







Net changes in operating assets and liabilities, net of amount acquired:





Trade receivables, net and unbilled receivables

712

(2,416)

Deferred tax assets

(1,435)

(300)

Other operating assets

(356)

(886)

Trade payables

190

(4,853)

Other operating liabilities

152

(4,691)

Deferred revenues

4,760

6,888

Severance pay

34

56







Net cash provided by operating activities

26,057

9,821







Cash flows from investing activities:





Purchase of property and equipment

(1,720)

(879)

Investment in deposit

(1,119)

-

Payments for business acquisition, net of cash acquired

-

(18,203)

Proceeds from sale of property and equipment

821

-

Capitalized software development costs

(2,962)

(2,470)







Net cash used in investing activities

(4,980)

(21,552)







Cash flows from financing activities:





Proceeds from employee stock options exercised

78

128

Repayment of Series B Debentures

(9,898)

-

Repayment of loan

(4)

(27)

Payment of contingent considerations

(120)

(61)

Dividend to non-controlling interest

(66)

(47)







Net cash provided by financing activities

(10,010)

(7)







Effect of exchange rate changes on cash and cash equivalents

1,587

(522)







Increase (decrease) in cash and cash equivalents

12,654

(12,260)

Cash and cash equivalents at the beginning of period

64,628

71,467







Cash and cash equivalents at the end of period

77,282

59,207

 

Debentures Covenants

As of June 30, 2019, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures that it issued in September 2017, based on having achieved the following in its consolidated financial results:

Covenant 1

  • Target shareholders' equity (excluding minority interest): above $120 million.
  • Actual shareholders' equity equal to $219 million.

Covenant 2

  • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
  • Actual ratio of net financial indebtedness to net capitalization equal to -3.51%.

Covenant 3

  • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
  • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to -0.15.

 

 

Investors and Media Contact

Yaffa Cohen-Ifrah

Chief Marketing Officer and Head of Corporate Communications 

Sapiens International  

U.S. Mobile: +1-201-250-9414  

Mobile: +972 54-9099039   

Email: yaffa.cohen-ifrah@sapiens.com

 

 

 

Cision View original content:http://www.prnewswire.com/news-releases/sapiens-reports-second-quarter-2019-financial-results-300896181.html

SOURCE Sapiens International Corporation

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsSmall CapPress ReleasesAccounting newsBanking/Financial ServicesInsuranceissues
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!